Follow
Min Zhang
Min Zhang
Verified email at houstonmethodist.org
Title
Cited by
Cited by
Year
Autocrine/paracrine human growth hormone-stimulated MicroRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer
W Zhang, P Qian, X Zhang, M Zhang, H Wang, M Wu, X Kong, S Tan, ...
Journal of Biological Chemistry 290 (22), 13812-13829, 2015
1112015
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis
M Wu, X Zhang, W Zhang, YS Chiou, W Qian, X Liu, M Zhang, H Yan, S Li, ...
Nature communications 13 (1), 1371, 2022
1102022
NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression
S Tan, H Li, W Zhang, Y Shao, Y Liu, H Guan, J Wu, Y Kang, J Zhao, Q Yu, ...
Oncogene 37 (35), 4887-4900, 2018
1032018
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma
V Pandey, ZS Wu, M Zhang, R Li, J Zhang, T Zhu, PE Lobie
Breast Cancer Research 16, 1-20, 2014
872014
Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1
X Zhang, M Wu, QY Chong, W Zhang, P Qian, H Yan, W Qian, M Zhang, ...
Carcinogenesis 39 (12), 1506-1516, 2018
512018
Mn (II) mediated degradation of artemisinin based on Fe 3 O 4@ MnSiO 3-FA nanospheres for cancer therapy in vivo
J Chen, W Zhang, M Zhang, Z Guo, H Wang, M He, P Xu, J Zhou, Z Liu, ...
Nanoscale 7 (29), 12542-12551, 2015
512015
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma
X Kong, W Wu, Y Yuan, V Pandey, Z Wu, X Lu, W Zhang, Y Chen, M Wu, ...
Oncotarget 7 (20), 29465, 2016
462016
Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells
S Tan, K Ding, QY Chong, J Zhao, Y Liu, Y Shao, Y Zhang, Q Yu, Z Xiong, ...
Journal of Biological Chemistry 292 (33), 13551-13564, 2017
422017
Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
M Zhang, W Zhang, Z Wu, S Liu, L Sun, Y Zhong, X Zhang, X Kong, ...
Oncotarget 7 (3), 3267, 2015
332015
Machine learning uncovers cell identity regulator by histone code
B Xia, D Zhao, G Wang, M Zhang, J Lv, AS Tomoiaga, Y Li, X Wang, ...
Nature communications 11 (1), 2696, 2020
322020
Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer
W Zhang, M Wu, QY Chong, M Zhang, X Zhang, L Hu, Y Zhong, P Qian, ...
Cancer research 78 (17), 4915-4928, 2018
322018
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer
S Zhu, D Zhao, C Li, Q Li, W Jiang, Q Liu, R Wang, L Fazli, Y Li, L Zhang, ...
Oncogene 39 (1), 17-29, 2020
242020
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
V Pandey, M Zhang, QY Chong, M You, AR Raquib, AK Pandey, DX Liu, ...
Oncotarget 8 (44), 77268, 2017
152017
Broad genic repression domains signify enhanced silencing of oncogenes
D Zhao, L Zhang, M Zhang, B Xia, J Lv, X Gao, G Wang, Q Meng, Y Yi, ...
Nature communications 11 (1), 5560, 2020
142020
Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
V Pandey, M Zhang, M You, W Zhang, R Chen, W Zhang, L Ma, ZS Wu, ...
Cell death & disease 9 (12), 1147, 2018
132018
CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells
D Zhao, M Zhang, S Huang, Q Liu, S Zhu, Y Li, W Jiang, DL Kiss, Q Cao, ...
Nucleic acids research 50 (21), 12186-12201, 2022
72022
SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy
Y Jung, TMA Abdel-Fatah, SYT Chan, CC Nolan, AR Green, IO Ellis, L Li, ...
Cancer research 73 (23), 6951-6962, 2013
72013
ARTEMIN promotes oncogenicity and resistance to 5-fluorouracil in colorectal carcinoma by p44/42 MAPK dependent expression of CDH2
QS Zhuang, XB Sun, QY Chong, A Banerjee, M Zhang, ZS Wu, T Zhu, ...
Frontiers in Oncology 11, 712348, 2021
52021
The therapeutic potential of targeting the CHD protein family in cancer
M Zhang, K Wu, W Zhang, X Lin, Q Cao, L Zhang, K Chen
Pharmacology & Therapeutics, 108610, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–19